全文获取类型
收费全文 | 2306篇 |
免费 | 115篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 107篇 |
妇产科学 | 49篇 |
基础医学 | 257篇 |
口腔科学 | 55篇 |
临床医学 | 217篇 |
内科学 | 576篇 |
皮肤病学 | 74篇 |
神经病学 | 114篇 |
特种医学 | 294篇 |
外科学 | 247篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 133篇 |
眼科学 | 39篇 |
药学 | 103篇 |
中国医学 | 4篇 |
肿瘤学 | 167篇 |
出版年
2023年 | 15篇 |
2022年 | 7篇 |
2021年 | 34篇 |
2020年 | 24篇 |
2019年 | 45篇 |
2018年 | 61篇 |
2017年 | 35篇 |
2016年 | 35篇 |
2015年 | 41篇 |
2014年 | 55篇 |
2013年 | 68篇 |
2012年 | 108篇 |
2011年 | 108篇 |
2010年 | 91篇 |
2009年 | 124篇 |
2008年 | 92篇 |
2007年 | 120篇 |
2006年 | 92篇 |
2005年 | 82篇 |
2004年 | 66篇 |
2003年 | 65篇 |
2002年 | 77篇 |
2001年 | 78篇 |
2000年 | 72篇 |
1999年 | 48篇 |
1998年 | 90篇 |
1997年 | 83篇 |
1996年 | 65篇 |
1995年 | 58篇 |
1994年 | 51篇 |
1993年 | 45篇 |
1992年 | 39篇 |
1991年 | 35篇 |
1990年 | 37篇 |
1989年 | 47篇 |
1988年 | 41篇 |
1987年 | 36篇 |
1986年 | 34篇 |
1985年 | 29篇 |
1984年 | 21篇 |
1983年 | 16篇 |
1982年 | 17篇 |
1981年 | 10篇 |
1980年 | 15篇 |
1979年 | 10篇 |
1978年 | 9篇 |
1977年 | 18篇 |
1976年 | 14篇 |
1975年 | 16篇 |
1972年 | 3篇 |
排序方式: 共有2497条查询结果,搜索用时 15 毫秒
1.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
2.
Amalia Moreno Concepción Montón Yolanda Belmonte Miguel Gallego Xavier Pomares Jordi Real 《Archivos de bronconeumologia》2009,45(4):181-185
ObjectiveThe objective of this study was to assess the causes of death and risk factors for mortality in a cohort of patients with severe chronic obstructive pulmonary disease (COPD).Patients and methodsWe studied 203 patients with severe COPD (forced expiratory volume in 1 second [FEV1] <50%), who were attended in our respiratory department day hospital (2001-2006). Clinical variables were recorded on inclusion, and clinical course and causes of death were retrospectively reviewed.ResultsThe mean (SD) age of patients was 69 (8) years and the mean FEV1 was 30.8% (8.2%). One-hundred and nine patients died (53.7%); death was attributed to respiratory causes in 72 (80.9%), with COPD exacerbation being the most frequent specific cause within this category (48.3%). During follow-up, 18.7% required admission to the intensive care unit (ICU). Survival at 1, 3, and 5 years was 80%, 53%, and 26%, respectively. The multivariate analysis showed that mortality was associated with age, stage IV classification according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), cor pulmonale, and hospital admission during the year prior to inclusion. Need for admission to the ICU during follow-up was a factor independently associated with higher mortality.ConclusionsMortality in patients with severe COPD was high and exacerbation of the disease was one of the most frequent causes of death. Age, GOLD stage, cor pulmonale, prior admission to hospital, and need for admission to the ICU during follow-up were independent predictors of mortality. 相似文献
3.
4.
5.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
6.
7.
8.
9.
SUMMARY A young patient presenting with splenomegaly and hypersplenism was inadvertently found to have selective IgA deficiency. There were no symptoms of immunodeficiency and the patient responded well to splenectomy, with return of blood counts to normal without adverse effects. No other cause for the hypersplenism was found. We postulate selective IgA deficiency as a cause of splenomegaly and hypersplenism. 相似文献
10.